327 related articles for article (PubMed ID: 9076381)
1. Antithrombin III supplementation for patients undergoing PTCA for unstable angina pectoris. A controlled randomized double-blind pilot study.
Grip L; Blombäck M; Egberg N; Olsson A; Svane B; Velander M
Eur Heart J; 1997 Mar; 18(3):443-9. PubMed ID: 9076381
[TBL] [Abstract][Full Text] [Related]
2. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
Hafner G; Rupprecht HJ; Luz M; Terres W; Schindel F; Friesen HJ; Heinrichs H; Jessel A; Meyer J; Prellwitz W
Eur Heart J; 1996 Aug; 17(8):1207-15. PubMed ID: 8869862
[TBL] [Abstract][Full Text] [Related]
3. Adjunctive intracoronary infusion of antithrombin III during percutaneous transluminal coronary angioplasty. Results of a prospective, randomized trial.
Schächinger V; Allert M; Kasper W; Just H; Vach W; Zeiher AM
Circulation; 1994 Nov; 90(5):2258-66. PubMed ID: 7955182
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: effects on inflammatory, hemostatic, and endothelium-derived parameters.
Suzuki S; Matsuo T; Kobayashi H; Matsuo M; Shimamo C; Koide M; Sakamoto S
Thromb Res; 2000 May; 98(4):269-79. PubMed ID: 10822073
[TBL] [Abstract][Full Text] [Related]
5. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive infusion of antithrombin III during percutaneous transluminal coronary angioplasty.
Huber K; Maurer G
Eur Heart J; 1997 Mar; 18(3):362-3. PubMed ID: 9076371
[No Abstract] [Full Text] [Related]
7. Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.
Gold HK; Torres FW; Garabedian HD; Werner W; Jang IK; Khan A; Hagstrom JN; Yasuda T; Leinbach RC; Newell JB
J Am Coll Cardiol; 1993 Apr; 21(5):1039-47. PubMed ID: 8459055
[TBL] [Abstract][Full Text] [Related]
8. Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, Early Administration of Reviparin in a Double-Blind Unfractionated Heparin and Placebo-Controlled Evaluation.
Karsch KR; Preisack MB; Baildon R; Eschenfelder V; Foley D; Garcia EJ; Kaltenbach M; Meisner C; Selbmann HK; Serruys PW; Shiu MF; Sujatta M; Bonan R
J Am Coll Cardiol; 1996 Nov; 28(6):1437-43. PubMed ID: 8917255
[TBL] [Abstract][Full Text] [Related]
9. Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcome in unstable angina pectoris.
Laskey MA; Deutsch E; Barnathan E; Laskey WK
Am J Cardiol; 1990 Jun; 65(22):1425-9. PubMed ID: 2353646
[TBL] [Abstract][Full Text] [Related]
10. Changes of hemostasis, endogenous fibrinolysis, platelet activation and endothelins after percutaneous transluminal coronary angioplasty in patients with stable angina.
Borries M; Heins M; Fischer Y; Stiegler H; Peters A; Reinauer H; Schoebel FC; Strauer BE; Leschke M
J Am Coll Cardiol; 1999 Aug; 34(2):486-93. PubMed ID: 10440163
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty.
van den Bos AA; Deckers JW; Heyndrickx GR; Laarman GJ; Suryapranata H; Zijlstra F; Close P; Rijnierse JJ; Buller HR; Serruys PW
Circulation; 1993 Nov; 88(5 Pt 1):2058-66. PubMed ID: 8222099
[TBL] [Abstract][Full Text] [Related]
12. Recombinant hirudin (HBW 023) prevents troponin T release after coronary angioplasty in patients with unstable angina.
Rupprecht HJ; Terres W; Ozbek C; Luz M; Jessel A; Hafner G; vom Dahl J; Kromer EP; Prellwitz W; Meyer J
J Am Coll Cardiol; 1995 Dec; 26(7):1637-42. PubMed ID: 7594097
[TBL] [Abstract][Full Text] [Related]
13. Role of prolonged intravenous heparin in unstable angina patients prior to coronary angioplasty.
Gangasani SR; O'Neill WW; Grines CL
J Interv Cardiol; 2001 Aug; 14(4):423-8. PubMed ID: 12053496
[TBL] [Abstract][Full Text] [Related]
14. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators.
Serruys PW; Herrman JP; Simon R; Rutsch W; Bode C; Laarman GJ; van Dijk R; van den Bos AA; Umans VA; Fox KA
N Engl J Med; 1995 Sep; 333(12):757-63. PubMed ID: 7643882
[TBL] [Abstract][Full Text] [Related]
15. Activated clotting times in acute coronary syndromes and percutaneous transluminal coronary angioplasty.
Wilson JM; Dougherty KG; Ellis KO; Ferguson JJ
Cathet Cardiovasc Diagn; 1995 Jan; 34(1):1-5. PubMed ID: 7728844
[TBL] [Abstract][Full Text] [Related]
16. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial comparing intravenous nitroglycerin and heparin for treatment of unstable angina secondary to restenosis after coronary artery angioplasty.
Doucet S; Malekianpour M; Théroux P; Bilodeau L; Côté G; de Guise P; Dupuis J; Joyal M; Gosselin G; Tanguay JF; Juneau M; Harel F; Nattel S; Tardif JC; Lespérance J
Circulation; 2000 Mar; 101(9):955-61. PubMed ID: 10704160
[TBL] [Abstract][Full Text] [Related]
18. Identifying patients at high risk for restenosis after percutaneous transluminal coronary angioplasty for unstable angina pectoris.
Halon DA; Merdler A; Shefer A; Flugelman MY; Lewis BS
Am J Cardiol; 1989 Aug; 64(5):289-93. PubMed ID: 2526992
[TBL] [Abstract][Full Text] [Related]
19. [Low molecular weight heparin, reviparin, after PTCA: results of a randomized double-blind, standard heparin and placebo controlled multicenter study (REDUCE Study].
Preisack MB; Baildon R; Eschenfelder V; Foley D; Garcia E; Kaltenbach M; Meisner C; Selbmann HK; Serruys PW; Shiu MF; Sujatta M; Bonan R; Karsch KR
Z Kardiol; 1997 Aug; 86(8):581-91. PubMed ID: 9417748
[TBL] [Abstract][Full Text] [Related]
20. Aggressive clinical pattern of angina at restenosis following coronary angioplasty in unstable angina.
Foley JB; Chisholm RJ; Common AA; Langer A; Armstrong PW
Am Heart J; 1992 Nov; 124(5):1174-80. PubMed ID: 1442483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]